Compound erythromycin sustained release preparation and its in vitro release / 药学学报
Acta Pharmaceutica Sinica
;
(12): 1385-1389, 2011.
Article
in Chinese
| WPRIM
| ID: wpr-323112
ABSTRACT
Using the weight-average molecular weight 50 000 polylactic acid (PLA) as a carrier, and a certain proportion of erythromycin (EM) and prednisone acetate (PNA) to mixed prepare the compound erythromycin sustained release preparation (sustained-release tablets). Using ultraviolet spectrophotometry and high performance liquid chromatography (HPLC) to detect separately the release amount of EM and PNA in vitro medium. The sustained-release tablets release for about 21 days, the average content of EM is 99.7 mg/table, RSD = 0.82%; and the average content of PNA is 10.03 mg/table, RSD = 0.93%. Within 21 days, the cumulative releases of EM and PNA are 86.1% and 78.3%, respectively. The drug release is steady and slow after 5 days, the burst release phenomenon in early stage is more significant. The results showed that the sustained-release tablet preparation method is feasible, the release performance is good and the clinical efficacy is significant.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Polyesters
/
Polymers
/
Sinusitis
/
Spectrophotometry, Ultraviolet
/
Tablets
/
Prednisone
/
Drug Carriers
/
Chemistry
/
Erythromycin
/
Chromatography, High Pressure Liquid
Limits:
Humans
Language:
Chinese
Journal:
Acta Pharmaceutica Sinica
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS